| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $377.0K | $108.0K | $300.0K |
| YoY Revenue Growth % | +249.1% | -64.0% | — |
| Gross Profit | $179.0K | $37.0K | — |
| Gross Margin % | 47.5% | 34.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.2M | -$1.0M | -$802.0K |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | $1.2M | $985.0K | $726.0K |
| EBITDA (Normalized) | -$1.0M | -$963.4K | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$811.0K | -$918.0K | -$548.0K |
| Capital Expenditures (CapEx) | $205.0K | $77.0K | — |
| Free Cash Flow (FCF) | -$1.0M | -$995.0K | -$548.0K |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $750.0K | $1.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $100.0K | $851.0K | — |